國立虎尾科技大學 |

Mesothelioma = From Research to Clinical Practice /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Mesothelioma/ edited by Giovanni Luca Ceresoli, Emilio Bombardieri, Maurizio D'Incalci.
Reminder of title:	From Research to Clinical Practice /
other author:	Ceresoli, Giovanni Luca.
Description:	XII, 340 p. 82 illus., 56 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-3-030-16884-1
ISBN:	9783030168841

Mesothelioma = From Research to Clinical Practice /
MesotheliomaFrom Research to Clinical Practice /[electronic resource] :edited by Giovanni Luca Ceresoli, Emilio Bombardieri, Maurizio D'Incalci. - 1st ed. 2019. - XII, 340 p. 82 illus., 56 illus. in color.online resource.

Epidemiology of mesothelioma -- Asbestos and pathophysiology of mesothelioma -- Screening issues in exposed subjects and early diagnosis -- Genetics and epigenetics of mesothelioma -- Microenvironment and immunology of mesothelioma -- Pre clinical models in mesothelioma -- Pathological diagnosis of mesothelioma -- Tissue and circulating biomarkers in mesothelioma -- Diagnostic imaging of mesothelioma -- Measuring malignant pleural mesothelioma -- Role of metabolic imaging in mesothelioma -- Staging of malignant pleural mesothelioma -- Surgery and multimodality treatment in malignant pleural mesothelioma -- Role of radiotherapy in malignant pleural mesothelioma -- Role of chemotherapy in malignant pleural mesothelioma -- Targeting angiogenesis in mesothelioma -- Targeted therapies in mesothelioma -- Mesothelin-targeting agents in mesothelioma -- Immunotherapy of mesothelioma: vaccines and cell therapy -- Immunotherapy of mesothelioma: immune checkpoints inhibitors -- Peritoneal mesothelioma: diagnosis and management -- Rare localizations of mesothelioma -- Unmet needs and future outlook of mesothelioma management.

This book offers an updated review of malignant mesothelioma, including the latest advances in our understanding of its genetic control and molecular biology, as well as pre-clinical and clinical research. It also presents state-of-the-art diagnostic approaches and therapeutic options, and an open discussion on the future prospects for patient management. Malignant mesothelioma is an enormous global health problem related to asbestos exposure. Despite the best efforts of scientists and oncologists, the prognosis for those affected remains poor. Due to anatomical characteristics and non-specific symptoms, the diagnosis of mesothelioma at an early stage is often difficult, while surgery and radiotherapy are only of limited use, even if some multimodality approaches seem promising. In turn, medical treatments are sometimes successful in tumor control, but have little impact on overall survival. However, advances in our understanding of the disease’s biology, together with the availability of new drugs and combinations, make mesothelioma an essential and highly topical field for pre-clinical and clinical studies. This book is subdivided into four parts: epidemiology and preclinical data, diagnosis, therapy, and extrathoracic mesothelioma. It highlights the progress made in a variety of areas – e.g. in vitro and in vivo experimental models, genetics, environment, biomarkers, targeting agents, immunotherapy, metabolic imaging and ongoing clinical trials – and describes the standard clinical management of mesothelioma patients, including those with extra-thoracic localizations. Given its scope, the book offers an invaluable tool for researchers, oncologists and clinicians alike.

ISBN: 9783030168841

Standard No.: 10.1007/978-3-030-16884-1doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Mesothelioma = From Research to Clinical Practice /
LDR:04216nam a22003975i 4500 001 1014940
003 DE-He213
005 20200704131818.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030168841 $9 978-3-030-16884-1
024 7 $a 10.1007/978-3-030-16884-1 $2 doi
035 $a 978-3-030-16884-1
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Mesothelioma $h [electronic resource] : $b From Research to Clinical Practice / $c edited by Giovanni Luca Ceresoli, Emilio Bombardieri, Maurizio D'Incalci.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XII, 340 p. 82 illus., 56 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Epidemiology of mesothelioma -- Asbestos and pathophysiology of mesothelioma -- Screening issues in exposed subjects and early diagnosis -- Genetics and epigenetics of mesothelioma -- Microenvironment and immunology of mesothelioma -- Pre clinical models in mesothelioma -- Pathological diagnosis of mesothelioma -- Tissue and circulating biomarkers in mesothelioma -- Diagnostic imaging of mesothelioma -- Measuring malignant pleural mesothelioma -- Role of metabolic imaging in mesothelioma -- Staging of malignant pleural mesothelioma -- Surgery and multimodality treatment in malignant pleural mesothelioma -- Role of radiotherapy in malignant pleural mesothelioma -- Role of chemotherapy in malignant pleural mesothelioma -- Targeting angiogenesis in mesothelioma -- Targeted therapies in mesothelioma -- Mesothelin-targeting agents in mesothelioma -- Immunotherapy of mesothelioma: vaccines and cell therapy -- Immunotherapy of mesothelioma: immune checkpoints inhibitors -- Peritoneal mesothelioma: diagnosis and management -- Rare localizations of mesothelioma -- Unmet needs and future outlook of mesothelioma management.
520 $a This book offers an updated review of malignant mesothelioma, including the latest advances in our understanding of its genetic control and molecular biology, as well as pre-clinical and clinical research. It also presents state-of-the-art diagnostic approaches and therapeutic options, and an open discussion on the future prospects for patient management. Malignant mesothelioma is an enormous global health problem related to asbestos exposure. Despite the best efforts of scientists and oncologists, the prognosis for those affected remains poor. Due to anatomical characteristics and non-specific symptoms, the diagnosis of mesothelioma at an early stage is often difficult, while surgery and radiotherapy are only of limited use, even if some multimodality approaches seem promising. In turn, medical treatments are sometimes successful in tumor control, but have little impact on overall survival. However, advances in our understanding of the disease’s biology, together with the availability of new drugs and combinations, make mesothelioma an essential and highly topical field for pre-clinical and clinical studies. This book is subdivided into four parts: epidemiology and preclinical data, diagnosis, therapy, and extrathoracic mesothelioma. It highlights the progress made in a variety of areas – e.g. in vitro and in vivo experimental models, genetics, environment, biomarkers, targeting agents, immunotherapy, metabolic imaging and ongoing clinical trials – and describes the standard clinical management of mesothelioma patients, including those with extra-thoracic localizations. Given its scope, the book offers an invaluable tool for researchers, oncologists and clinicians alike.
650 0 $a Oncology . $3 1253469
650 0 $a Nuclear medicine. $3 673902
650 0 $a Molecular biology. $3 583443
650 0 $a Bioinformatics. $3 583857
650 0 $a Human genetics. $3 596505
650 0 $a Immunology. $3 592892
650 1 4 $a Oncology. $3 593951
650 2 4 $a Nuclear Medicine. $3 673045
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Human Genetics. $3 593893
700 1 $a Ceresoli, Giovanni Luca. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1228690
700 1 $a Bombardieri, Emilio. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 678341
700 1 $a D'Incalci, Maurizio. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1228691
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030168834
776 0 8 $i Printed edition: $z 9783030168858
776 0 8 $i Printed edition: $z 9783030168865
856 4 0 $u https://doi.org/10.1007/978-3-030-16884-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)